Higher NT-proBNP levels and the risk of intradialytic hypotension at hemodialysis initiation

被引:4
作者
Curtis, Katherine A. [1 ,2 ,3 ]
Waikar, Sushrut S. [4 ]
Mc Causland, Finnian R. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Renal Med, 45 Francis St,Med Res Bldg,Suite 416, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA
[4] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA USA
关键词
hemodialysis; hypervolemia; hypotension; NT-proBNP; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR MORBIDITY; MORTALITY RISK; ASSOCIATION; DIALYSIS; DEFINITIONS; PREDICTORS; OVERLOAD; ESRD;
D O I
10.1111/hdi.13125
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Elevated N-terminal pro B-type natriuretic peptide (NT-proBNP) is a potent predictor of adverse outcomes in hemodialysis initiation. These patients often experience intradialytic hypotension, which may partially reflect cardiac dysfunction, but the association of NT-proBNP with intradialytic hypotension is not clear.Methods: We performed a post hoc analysis of a randomized trial that tested mannitol versus placebo in 52 patients initiating hemodialysis (NCT01520207). NT-proBNP was measured prior to the first and third sessions (n = 87). Mixed-effects models (adjusting for randomized treatment, sex, race, age, diabetes, heart failure, catheter use, pre-dialysis systolic blood pressure, pre-dialysis weight, ultrafiltration volume, serum sodium, bicarbonate, urea nitrogen, phosphate, albumin, hemoglobin, and session length) were fit to examine the association of NT-proBNP with systolic blood pressure decline (pre-dialysis minus nadir systolic blood pressure). Additionally, mixed-effects Poisson models were fit to examine the association with intradialytic hypotension (>= 20 mmHg decline in systolic blood pressure).Findings: Mean age was 55 +/- 16 years; 33% had baseline heart failure. The median NT-proBNP was 5498 [25th-75th percentile 2011, 14,790] pg/mL; 26 sessions (30%) were complicated by intradialytic hypotension. In adjusted models, each unit higher log-NT-proBNP was associated with 6.0 mmHg less decline in systolic blood pressure (95%CI -9.2 to -2.8). Higher pre-dialysis NT-proBNP, per log-unit, was associated with a 52% lower risk of intradialytic hypotension (IRR 0.48, 95%CI 0.23-0.97), without evidence for effect modification by randomized treatment (P-interaction = 0.17).Discussion: In patients initiating hemodialysis, higher NT-proBNP is associated with less decline in intradialytic systolic blood pressure and lower risk of intradialytic hypotension. Future studies should investigate if higher pre-dialysis NT-proBNP levels may identify patients who might tolerate more aggressive ultrafiltration.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [31] Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
    Kim, H. M.
    Choo, Y. S.
    Seong, W. J.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2020, 47 (04) : 511 - 515
  • [32] Enhancing risk stratification post-myocardial infarction: prognostic value of NT-proBNP and fQRS
    Pannu, Ashok Kumar
    BIOMARKERS IN MEDICINE, 2025,
  • [33] NT-proBNP levels and QT changes in acute ischemic stroke
    Acikalin, Ayca
    Satar, Salim
    Akpinar, Onur
    Cagliyan, Caglar Emre
    Sahan, Mustafa
    Icme, Ferhat
    Gulen, Muge
    Yildiz, Mehmet
    NEUROLOGY ASIA, 2013, 18 (01) : 1 - 8
  • [34] Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients
    Chou, Jason A.
    Streja, Elani
    Nguyen, Danh V.
    Rhee, Connie M.
    Obi, Yoshitsugu
    Inrig, Jula K.
    Amin, Alpesh
    Kovesdy, Csaba P.
    Sim, John J.
    Kalantar-Zadeh, Kamyar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (01) : 149 - 159
  • [35] Coronary artery calcification is a risk factor for intradialytic hypotension in patients undergoing hemodialysis
    Mizuiri, Sonoo
    Nishizawa, Yoshiko
    Doi, Toshiki
    Yamashita, Kazuomi
    Shigemoto, Kenichiro
    Usui, Koji
    Arita, Michiko
    Naito, Takayuki
    Doi, Shigehiro
    Masaki, Takao
    HEMODIALYSIS INTERNATIONAL, 2022, 26 (03) : 335 - 344
  • [36] Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major
    Delaporta, Polyxeni
    Kattamis, Antonios
    Apostolakou, Filia
    Boiu, Sorina
    Bartzeliotou, Anastasia
    Tsoukas, Evangelos
    Papassotiriou, Ioannis
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (01) : 20 - 24
  • [37] Relationships between NT-proBNP and novel biochemical parameters and increased cardiovascular risk in COVID-19 NT-proBNP levels and novel inflammatory biomarkers in COVID-19
    Altinbas, Ozgur
    Mete, Ayse Ozlem
    Demiryurek, Seniz
    Hafiz, Erhan
    Saracaloglu, Ahmet
    Demiryurek, Abdullah Tuncay
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 : 529 - 533
  • [38] Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure
    Lueers, C.
    Schmidt, A.
    Wachter, R.
    Fritzsche, F.
    Sutcliffe, A.
    Kleta, S.
    Zapf, A.
    Hagenah, G.
    Binder, L.
    Maisch, B.
    Pieske, B.
    HERZ, 2010, 35 (07) : 488 - 495
  • [39] Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
    Welsh, Paul
    Campbell, Ross T.
    Mooney, Leanne
    Kimenai, Dorien M.
    Hayward, Caroline
    Campbell, Archie
    Porteous, David
    Mills, Nicholas L.
    Lang, Ninian N.
    Petrie, Mark C.
    Januzzi, James L.
    McMurray, John J., V
    Sattar, Naveed
    CIRCULATION-HEART FAILURE, 2022, 15 (10) : E009427
  • [40] The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia
    Uyar, Ibrahim
    Kurt, Sefa
    Demirtas, Omer
    Gurbuz, Tutku
    Aldemir, Onur Suleyman
    Keser, Buket
    Tasyurt, Abdullah
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (06) : 1253 - 1258